Ortho Regenerative Technologies Inc. (OTCMKTS:ORTIF – Get Rating) was the recipient of a large increase in short interest in the month of August. As of August 15th, there was short interest totalling 1,500 shares, an increase of 1,400.0% from the July 31st total of 100 shares. Based on an average daily volume of 2,300 shares, the short-interest ratio is presently 0.7 days.
Ortho Regenerative Technologies Price Performance
OTCMKTS:ORTIF remained flat at $0.20 on Friday. The company has a market cap of $6.86 million, a P/E ratio of -1.78 and a beta of -1.22. Ortho Regenerative Technologies has a 1 year low of $0.13 and a 1 year high of $0.45. The firm's fifty day moving average is $0.20 and its 200-day moving average is $0.19.
Get Ortho Regenerative Technologies alerts:Ortho Regenerative Technologies (OTCMKTS:ORTIF – Get Rating) last announced its quarterly earnings results on Thursday, June 23rd. The company reported ($0.02) EPS for the quarter. Analysts predict that Ortho Regenerative Technologies will post -0.08 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
Separately, Noble Financial initiated coverage on shares of Ortho Regenerative Technologies in a research report on Monday, July 11th. They issued an "outperform" rating and a C$1.35 target price for the company.Ortho Regenerative Technologies Company Profile
(Get Rating)
Ortho Regenerative Technologies Inc, an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. It develops Ortho-R, a formulation for rotator cuff repair; Ortho-M, a biopolymer for meniscus repair; Ortho-C, a biopolymer for articular cartilage repair; and Ortho-V, a biopolymer for osteoarthritis healing, as well as ORTHO-T, a biopolymer formulation for tendon healing and regeneration.
Featured Articles
- Get a free copy of the StockNews.com research report on Ortho Regenerative Technologies (ORTIF)
- Why This Dip in Advanced Auto Parts May be an Opportunity
- MarketBeat: Week in Review 8/22 – 8/26
- Institutional Buying Put A Bottom In Marvell Technology
- Dell Stock Retreats On Weaker Sales, Falls Into Value Terrirtory
- 3 Reasons Dollar General's Rally Has Legs
Receive News & Ratings for Ortho Regenerative Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ortho Regenerative Technologies and related companies with MarketBeat.com's FREE daily email newsletter.